The new Contour blood glucose meter from Bayer HealthCare Diabetes Care promises enhanced testing features that can be personalised to meet diabetics individual treatments. The firm has also redesigned the Microlet 2 lancing system.
Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…
The probability of woman of suffering from cardiovascular diseases is often underestimated. A recent study evaluated the risk of nearly 9.000 women in the U.S. screened for heart-health risk: one in five women had a higher risk than measured by a frequently used predictor.
Tiny lipid-shelled microbubbles injected in vessels may serve as an new ultrasound contrast agent to evaluate microvascular blood flow. By this microbubbles US-researcher devised a ultrasound imaging technique that can spot early signs of PAD.
Diabetes fires researchers imagination: Two scientists at the University of Michigan Kellogg Eye Center developed a new screening device that gives early warnings of diabetes and its vision complications within five minutes.
The ankle brachial index, a ratio of blood pressure measurements used to indicate the risk of peripheral artery disease and atherosclerosis, may be useful to improve the accuracy of cardiovascular risk prediction, according to a meta-analysis of previous studies.
This week not only one but rather two studies report about a new and independent marker that is associated with type 2 diabetes. The protein that is called fetuin-A is produced in the liver and secreted to the blood stream also indicates a higher risk of developing diabetes disease.
Bayer loves sports. Therefore it developes medical devices to work under extremes. Recently extrem-athlete and diabetic Geri Winkler conquered the Seven Summits - a group of mountains comprising the highest peaks on each of the seven continents. The blood glucose monitoring system from Bayer HealthCare is always with him.
During the 2nd European Workshop on Diabetes, hosted by Bayer HealthCare Diabetes Care, experts called for uncompromising management of diabetes.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
Prevalence of adult obesity has increased three-fold since 1990. The prevalence of childhood obesity has increased ten times since 1970. In Europe, almost 50% of adults and over 20% of children are overweight. A third of these are obese. Conservative estimates show that, in Europe, about 100 million adults and 10 million children are obese. Obesity is accountable for c. one million deaths…
Since 2002 the number of children in England needing hospital care for complications of diabetes has risen about approximately 25 percent. The Patient group Diabetes UK blames cuts in the NHS service for this trend, BBC News reported yesterday.
Despite Hurricane Amma storming over Prague, hundreds of medical specialists paid little attention when they attended the 1st International Conference on Advanced Technologists and Treatments for Diabetes (ATTD), observed our Russian correspondent Olga Ostrovskaya, reporting on the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Prague (ATTD) held in…
Boston Scientific Corporation has announced results from a pooled analysis of patients from its TAXUS IV and TAXUS V randomised clinical trials to compare the safety and efficacy of the TAXUS Express Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients.
'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'
By Professor Jean-Charles Preiser MD PhD, of the Department of General Intensive Care, University Hospital Centre, University of Liege, Belgium
Type 2 diabetes poses one of the greatest public health threats of the 21st century. The majority of the western world is in the grips of a diabetes epidemic driven by type 2 diabetes that goes hand in hand with the escalating incidence of obesity. Alarmingly, in some working class and poor communities, the disease is so prevalent that its victims almost take it as a matter of course.
Presented during a symposium at Langenbeck-Virchow-Haus, in Berlin, the European CLINICIP research project aims to develop a method to improve glycaemic control during intensive care and provide a low-risk monitoring and control system that can control the metabolism of the critically ill
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
Heidelberger-Medical-Marketing GmbH (HMM) presented the first CE-Certified and EU-Registered blood glucose meter for self-monitoring with Bluetooth technology, the smartLABgenie at Medica on Wednesday.
The DCA Vantage Analyser from Siemens Medical Solutions Diagnostics is a user-friendly, point-of-care (POC) patient management platform for diabetes.
Michael Hall outlines the work and aims of IMAGE - the Development and Implementation of a European Guideline and Training Standards for Diabetes Prevention
The first wireless POC (Point of care) blood glucose and bedside testing solution for hospitals was launched by Bayer Healthcare during the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam this September.
The results of the blood pressure lowering arm of the ADVANCE (Action in Diabetes and Vascular Disease) study, the largest ever trial conducted in people with type 2 diabetes, were recently reported in the Lancet.